Microsoft Word - ELCID_Telemax Capital Increase       No. FER 600195 March 23, 2018 Subject : Notification of the capital increase and investment plan of its subsidiary Attention : President, The

sales revenue increased from THB 355.2 million to THB 374.3 million, respectively, representing an increase of 5.4%. The increase in sales revenue mainly due to higher sales revenue of our existing

international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

following significant Board’s resolutions:- 1. Approved the acquisition by the Company and its wholly ordinary shares of Aesthetic Zecret Co., Ltd. (“At-Ze”) from its ex-shareholders and will increase capital

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

Deduct Minority interest - - Net tangible assets (NTA) 604.68 (0.22) Plus Capital increase from ex-shareholder :At-Ze prior to share sale and purchase date* - 30.00 Net tangible assets (NTA)-adjusted

Intangible assets deduct 11.53 0.54 Deduct Total liabilities 315.37 157.34 Deduct Minority interest - - Net tangible assets (NTA) 604.68 (0.22) Plus Capital increase from ex-shareholder :At-Ze prior to share

690.75 million baht or an increase of 5.67 percent (2Q2019: 653.67 million baht). The profit before finance costs, tax, depreciation and amortization of 620.54 million baht or increased by 15.56 percent

will focus on more premium products to increase profitability, and more mass products to increase sales volume, both in the fruit juice category as well as other categories, which will also help reach